ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
123.725,06
0,88%
S&P 500
5.490,58
0,23%
US Dollar vs BRL
5,5155
-0,15%
Bitcoin
62.319,44
2,46%
Brent Oil
85,335
1,02%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Telomir Pharmaceuticals Inc (TELO)

  7. Telomir Pharmaceuticals Inc (TELO) Notícias

TELO

Telomir Pharmaceuticals (TELO)

Telomir Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TELO
DataHoraFonteTítuloCódigoCompanhia
17/06/202417:10GlobeNewswire Inc.Telomir Pharmaceuticals Scientific Advisor to Participate in Drug Information Association 2024 Global Annual Meeting PanelNASDAQ:TELOTelomir Pharmaceuticals Inc
30/05/202409:30GlobeNewswire Inc.Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1NASDAQ:TELOTelomir Pharmaceuticals Inc
24/05/202410:30GlobeNewswire Inc.New to The Street TV Announces Episode 575 with its Four Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV, Saturday, May 25, 2024, at 6:30 PM ETNASDAQ:TELOTelomir Pharmaceuticals Inc
16/05/202410:30GlobeNewswire Inc.Telomir Pharmaceuticals, Inc. Signs Media Deal with New to The Street for Network Interview Broadcasts, Billboards, and TV Commercial SupportNASDAQ:TELOTelomir Pharmaceuticals Inc
13/05/202417:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TELOTelomir Pharmaceuticals Inc
16/04/202409:30GlobeNewswire Inc.Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.NASDAQ:TELOTelomir Pharmaceuticals Inc
02/04/202409:30GlobeNewswire Inc.Telomir Pharmaceuticals’ Anti-Aging Expert and NYT Bestselling Author Michael F. Roizen, MD, to Present Promising Pre-Clinical Data for Age-Reversal Drug Telomir-1 at the National Press Club in Washington, DC, on April 15, 2024NASDAQ:TELOTelomir Pharmaceuticals Inc
29/03/202417:44GlobeNewswire Inc.UPDATE – Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in CaninesNASDAQ:TELOTelomir Pharmaceuticals Inc
26/03/202409:30GlobeNewswire Inc.Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in CaninesNASDAQ:TELOTelomir Pharmaceuticals Inc
22/03/202409:30GlobeNewswire Inc.Telomir Pharmaceuticals Releases New Pre-Clinical Data for Telomir-1 to Be Presented at the Global Longevity Federation Conference in Las Vegas on March 26thNASDAQ:TELOTelomir Pharmaceuticals Inc
14/03/202409:30GlobeNewswire Inc.Telomir Pharmaceuticals Uses AI Testing Models to Show its Lead Product Candidate’s Potential in DNA Age Reversal ScienceNASDAQ:TELOTelomir Pharmaceuticals Inc
07/03/202410:30GlobeNewswire Inc.Telomir Pharmaceuticals Presents Promising Pre-Clinical Data For Its Lead Development Product at Singapore ConferenceNASDAQ:TELOTelomir Pharmaceuticals Inc
05/03/202410:30GlobeNewswire Inc.Michael F. Roizen, MD to Increase Activities with Telomir Pharmaceuticals as Special Advisor on Age ReversalNASDAQ:TELOTelomir Pharmaceuticals Inc
13/02/202418:05GlobeNewswire Inc.Telomir Pharmaceuticals Announces Closing of Initial Public OfferingNASDAQ:TELOTelomir Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:TELO

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
AMER3
Americanas ON
BOV
PRIO3
PETRORIO ON
BOV
HBOR3
HELBOR ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
OIBR3
OI ON
BOV
COGN3
COGNA ON
BOV
SUZB3
SUZANO PAPEL ON
BOV
RNEW4
RENOVA PN
BOV
HAGA3
HAGA ON
BOV
DASA3
DASA ON
BOV
RCSL4
RECRUSUL PN
BOV
AZEV4
AZEVEDO PN
BOV
ENAT3
ENAUTA ON
BOV
GOLL4
GOL PN
BOV
TELB4
TELEBRAS PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados